John P. Schmid - Net Worth and Insider Trading

In summary, during the past 3 months, insiders sold 0 shares of Helix Acquisition Corp (HLXA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Helix Acquisition Corp (HLXA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Helix Acquisition Corp (HLXA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, John P. Schmid made no insider transaction in Poseida Therapeutics Inc (PSTX). Other recent insider transactions involving Poseida Therapeutics Inc (PSTX) include a net sale of 30,000 shares made by Mark J Gergen ,

In summary, during the past 3 months, insiders sold 30,000 shares of Poseida Therapeutics Inc (PSTX) in total and bought 0 shares, with a net sale of 30,000 shares. During the past 18 months, 30,000 shares of Poseida Therapeutics Inc (PSTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 30,000 shares.

Poseida Therapeutics Inc (PSTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Neos Therapeutics Inc (NEOS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Neos Therapeutics Inc (NEOS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Neos Therapeutics Inc (NEOS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, John P. Schmid made 5 insider transaction in Xeris Biopharma Holdings Inc (XERS) with a net purchase of 25,200. Other recent insider transactions involving Xeris Biopharma Holdings Inc (XERS) include a net purchase of 30,769 shares made by Shannon John Patrick Jr , a net purchase of 28,000 shares made by Steven Pieper , and a net purchase of 10,000 shares made by Paul R Edick .

In summary, during the past 3 months, insiders sold 0 shares of Xeris Biopharma Holdings Inc (XERS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Xeris Biopharma Holdings Inc (XERS) were sold and 104,779 shares were bought by its insiders, resulting in a net purchase of 104,779 shares.

Xeris Biopharma Holdings Inc (XERS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, John P. Schmid made no insider transaction in AnaptysBio Inc (ANAB). Other recent insider transactions involving AnaptysBio Inc (ANAB) include a net sale of 11,879 shares made by Paul F. Lizzul , a net sale of 26,687 shares made by Eric J Loumeau , and a net sale of 24,965 shares made by Dennis Mulroy .

In summary, during the past 3 months, insiders sold 28,440 shares of AnaptysBio Inc (ANAB) in total and bought 0 shares, with a net sale of 28,440 shares. During the past 18 months, 233,237 shares of AnaptysBio Inc (ANAB) were sold and 273,972 shares were bought by its insiders, resulting in a net purchase of 40,735 shares.

AnaptysBio Inc (ANAB)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, John P. Schmid made 1 insider transaction in Design Therapeutics Inc (DSGN) with a net purchase of 26,965. Other recent insider transactions involving Design Therapeutics Inc (DSGN) include a net purchase of 1,420,126 shares made by Arsani William , a net purchase of 21,000 shares made by Rodney W Lappe , and a net purchase of 12,000 shares made by Deepa Prasad .

In summary, during the past 3 months, insiders sold 0 shares of Design Therapeutics Inc (DSGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 814,874 shares of Design Therapeutics Inc (DSGN) were sold and 2,296,265 shares were bought by its insiders, resulting in a net purchase of 1,481,391 shares.

Design Therapeutics Inc (DSGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, John P. Schmid made no insider transaction in MoonLake Immunotherapeutics (MLTX). Other recent insider transactions involving MoonLake Immunotherapeutics (MLTX) include a net purchase of 802,051 shares made by Bihua Chen , a net sale of 200,000 shares made by Kristian Reich , and a net sale of 184,740 shares made by Santos Da Silva Jorge .

In summary, during the past 3 months, insiders sold 2,171,000 shares of MoonLake Immunotherapeutics (MLTX) in total and bought 0 shares, with a net sale of 2,171,000 shares. During the past 18 months, 2,655,740 shares of MoonLake Immunotherapeutics (MLTX) were sold and 802,051 shares were bought by its insiders, resulting in a net sale of 1,853,689 shares.

MoonLake Immunotherapeutics (MLTX)'s detailed insider trading history can be found in Insider Trading Tracker table.